At the end of the webinar, learners will be able to:
- Understand the preclinical rationale for synergy in combining radiotherapy and immunotherapy.
- Understand the unresolved questions around sequencing, dose/fractionation, abscopal effects, and sites of irradiation in combination therapy.
- Understand pertinent clinical trial evidence for the safety and efficacy of radiotherapy and immunotherapy combinations.
- Update key ongoing trials of RT-IO combo in the curative, oligometastatic and metastatic setting.